MwanzoDPM • FRA
add
Sumitomo Pharma Co Ltd
Bei iliyotangulia
€ 3.10
Bei za siku
€ 3.24 - € 3.24
Bei za mwaka
€ 1.64 - € 4.22
Thamani ya kampuni katika soko
218.85B JPY
Wastani wa hisa zilizouzwa
1.00
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
TYO
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (JPY) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 90.07B | 17.05% |
Matumizi ya uendeshaji wa biashara | 57.77B | -29.54% |
Mapato halisi | -48.17B | -66.80% |
Kiwango cha faida halisi | -53.47 | -42.51% |
Mapato kwa kila hisa | — | — |
EBITDA | 1.71B | 106.70% |
Asilimia ya kodi ya mapato | 2.91% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (JPY) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 99.08B | 64.05% |
Jumla ya mali | 799.76B | -30.39% |
Jumla ya dhima | 685.52B | -6.96% |
Jumla ya hisa | 114.24B | — |
hisa zilizosalia | 397.29M | — |
Uwiano wa bei na thamani | 0.01 | — |
Faida inayotokana na mali | -1.52% | — |
Faida inayotokana mtaji | -2.41% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (JPY) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -48.17B | -66.80% |
Pesa kutokana na shughuli | 29.60B | 166.77% |
Pesa kutokana na uwekezaji | -4.67B | 19.25% |
Pesa kutokana na ufadhili | -192.00M | -101.71% |
Mabadiliko halisi ya pesa taslimu | 20.68B | 160.69% |
Mtiririko huru wa pesa | -5.37B | 80.78% |
Kuhusu
Sumitomo Pharma Company Limited is a Japanese multinational pharmaceutical company. The company is focused on oncology, psychiatry, neurology, women's health issues, urological diseases among other areas. Its headquarters are located in Chuo-ku, Osaka. Wikipedia
Ilianzishwa
14 Mei 1897
Makao Makuu
Tovuti
Wafanyakazi
4,980
